FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904352103> ?p ?o ?g. }

• W2904352103 endingPage "12" @default.
• W2904352103 startingPage "1" @default.
• W2904352103 abstract "The development of somatostatin analogs for the treatment of pituitary Cushing’s disease has been based on somatostatin receptor expression analyses of small cohorts of pituitary adenomas. Additionally, the classification of pituitary adenomas has recently changed. To enable progress with this treatment option, we assessed somatostatin receptors in a large cohort of corticotroph and other pituitary adenomas according to the new WHO classification of endocrine tumors. Paraffin-embedded tumor samples of 88 corticotroph pituitary adenomas and 30 nonadenomatous pituitary biopsies were analyzed after processing into tissue microarrays and immunohistochemical staining for SSTR 1, SSTR2A, SSTR3, SSTR4, and SSTR5. For comparison, 159 other noncorticotroph pituitary adenomas were analyzed. SSTR3 expression was higher in corticotroph adenomas compared to PIT-1-positive, gonadotroph, and nonfunctioning pituitary adenomas (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M1><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:math>, <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M2><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0280</mml:mn></mml:math>, and <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M3><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:math>, respectively). This was also the case for the expression of SSTR5 (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M4><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0003</mml:mn></mml:math>, <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M5><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:math>, and <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M6><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:math>, respectively). SSTR2A expression was higher compared to gonadotroph and nonfunctioning pituitary adenomas (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M7><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0217</mml:mn></mml:math> and 0.0126, respectively) while PIT-1-positive adenomas showed even higher SSTR2A expression (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M8><mml:mi>p</mml:mi><mml:mo><</mml:mo><mml:mn>0.0001</mml:mn></mml:math>). SSTR2A and SSTR5 were both expressed higher in nonadenomatous pituitary biopsies than in pituitary adenomas (<mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M9><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0126</mml:mn></mml:math> and <mml:math xmlns:mml=http://www.w3.org/1998/Math/MathML id=M10><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0008</mml:mn></mml:math>, respectively). There are marked expression differences of SSTR1-5 as well as changes in expression in recurrent disease that need to be addressed when looking for other possible substances for the treatment of Cushing’s disease. SSTR2A, SSTR3, and SSTR5 seem to be most suitable biomarkers for a targeted therapy with somatostatin analogs." @default.
• W2904352103 created "2018-12-22" @default.
• W2904352103 creator A5008008737 @default.
• W2904352103 creator A5029875111 @default.
• W2904352103 creator A5035405804 @default.
• W2904352103 creator A5040991417 @default.
• W2904352103 creator A5044195004 @default.
• W2904352103 creator A5086702494 @default.
• W2904352103 creator A5091648075 @default.
• W2904352103 date "2018-12-09" @default.
• W2904352103 modified "2023-10-18" @default.
• W2904352103 title "High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma" @default.
• W2904352103 cites W1910274646 @default.
• W2904352103 cites W1957624608 @default.
• W2904352103 cites W1998001019 @default.
• W2904352103 cites W1998767852 @default.
• W2904352103 cites W2007536764 @default.
• W2904352103 cites W2011696525 @default.
• W2904352103 cites W2013013445 @default.
• W2904352103 cites W2015321769 @default.
• W2904352103 cites W2042625467 @default.
• W2904352103 cites W2044656399 @default.
• W2904352103 cites W2048723822 @default.
• W2904352103 cites W2050316046 @default.
• W2904352103 cites W2055303836 @default.
• W2904352103 cites W2057835402 @default.
• W2904352103 cites W2058903385 @default.
• W2904352103 cites W2064227011 @default.
• W2904352103 cites W2065131235 @default.
• W2904352103 cites W2071310612 @default.
• W2904352103 cites W2084087648 @default.
• W2904352103 cites W2086924944 @default.
• W2904352103 cites W2095640694 @default.
• W2904352103 cites W2099447985 @default.
• W2904352103 cites W2108613323 @default.
• W2904352103 cites W2116872598 @default.
• W2904352103 cites W2118708995 @default.
• W2904352103 cites W2123601063 @default.
• W2904352103 cites W2133418708 @default.
• W2904352103 cites W2150185213 @default.
• W2904352103 cites W2151336122 @default.
• W2904352103 cites W2167895760 @default.
• W2904352103 cites W2168291388 @default.
• W2904352103 cites W2252521414 @default.
• W2904352103 cites W2286296536 @default.
• W2904352103 cites W2326388815 @default.
• W2904352103 cites W2579290399 @default.
• W2904352103 cites W2746574162 @default.
• W2904352103 cites W2763024200 @default.
• W2904352103 cites W2763207751 @default.
• W2904352103 doi "https://doi.org/10.1155/2018/1763735" @default.
• W2904352103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6304820" @default.
• W2904352103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30627156" @default.
• W2904352103 hasPublicationYear "2018" @default.
• W2904352103 type Work @default.
• W2904352103 sameAs 2904352103 @default.
• W2904352103 citedByCount "14" @default.
• W2904352103 countsByYear W29043521032019 @default.
• W2904352103 countsByYear W29043521032020 @default.
• W2904352103 countsByYear W29043521032021 @default.
• W2904352103 countsByYear W29043521032023 @default.
• W2904352103 crossrefType "journal-article" @default.
• W2904352103 hasAuthorship W2904352103A5008008737 @default.
• W2904352103 hasAuthorship W2904352103A5029875111 @default.
• W2904352103 hasAuthorship W2904352103A5035405804 @default.
• W2904352103 hasAuthorship W2904352103A5040991417 @default.
• W2904352103 hasAuthorship W2904352103A5044195004 @default.
• W2904352103 hasAuthorship W2904352103A5086702494 @default.
• W2904352103 hasAuthorship W2904352103A5091648075 @default.
• W2904352103 hasBestOaLocation W29043521031 @default.
• W2904352103 hasConcept C11413529 @default.
• W2904352103 hasConcept C126322002 @default.
• W2904352103 hasConcept C134018914 @default.
• W2904352103 hasConcept C204232928 @default.
• W2904352103 hasConcept C2776297358 @default.
• W2904352103 hasConcept C2777428134 @default.
• W2904352103 hasConcept C2779029589 @default.
• W2904352103 hasConcept C2779318953 @default.
• W2904352103 hasConcept C41008148 @default.
• W2904352103 hasConcept C71315377 @default.
• W2904352103 hasConcept C71924100 @default.
• W2904352103 hasConcept C79381400 @default.
• W2904352103 hasConcept C80115893 @default.
• W2904352103 hasConceptScore W2904352103C11413529 @default.
• W2904352103 hasConceptScore W2904352103C126322002 @default.
• W2904352103 hasConceptScore W2904352103C134018914 @default.
• W2904352103 hasConceptScore W2904352103C204232928 @default.
• W2904352103 hasConceptScore W2904352103C2776297358 @default.
• W2904352103 hasConceptScore W2904352103C2777428134 @default.
• W2904352103 hasConceptScore W2904352103C2779029589 @default.
• W2904352103 hasConceptScore W2904352103C2779318953 @default.
• W2904352103 hasConceptScore W2904352103C41008148 @default.
• W2904352103 hasConceptScore W2904352103C71315377 @default.
• W2904352103 hasConceptScore W2904352103C71924100 @default.
• W2904352103 hasConceptScore W2904352103C79381400 @default.
• W2904352103 hasConceptScore W2904352103C80115893 @default.
• W2904352103 hasFunder F4320320879 @default.
• W2904352103 hasLocation W29043521031 @default.

• next